Literature DB >> 33510184

An evaluation of lipid profile and pro-inflammatory cytokines as determinants of cardiovascular disease in those with diabetes: a study on a Mexican American cohort.

Amna Tahir1, Perla J Martinez2, Fayyaz Ahmad3, Susan P Fisher-Hoch2, Jennifer L Gay4, Shaper Mirza5, Safee Ullah Chaudhary6.   

Abstract

Sedentary life styles coupled with high-calorie diets and unhealthy social habits such as smoking, have put an ever-increasing number of people at risk of cardiovascular disorders (CVD), worldwide. A concomitant increase in the prevalence of type 2-diabetes (hyperglycemia), a risk factor for CVD, has further contributed towards escalating CVD-related mortalities. The increase in number of cases of type 2-diabetes underscores the importance of early diagnosis of cardiovascular disease in those with diabetes. In this work, we have evaluated the sensitivity and specificity of dyslipidemia and proinflammatory cytokines to be used as biomarkers for predicting the risk of CVD in those with diabetes. We hypothesize that interplay between dyslipidemia and diabetes-induced low-grade inflammation in those with type 2-diabetes increases the risk of CVD. A total of 215 participants were randomly recruited from the Cameron County Hispanic Cohort (CCHC). Of these, 99% were Mexican Americans living on Texas-Mexico border. Levels of cytokines, adipokines and lipid profile were measured. Cardiovascular disease (CVD) for this study was defined as prior diagnosis of heart attack, angina and stroke, while diabetes was defined by fasting blood glucose (FBG) of > 100 mg/dL and HbA1c of > 6.5, in accordance with American Diabetes Association (ADA) guidelines. Depending on type and distribution of data, various statistical tests were performed. Our results demonstrated higher rates of heart attack (14% vs 11.8%) and stroke (19.8% vs 10%) in those with diabetes as compared to non-diabetes. The odds of having a heart attack were eight times higher in the presence of elevated triglycerides and pro-inflammatory markers (TNFα and IL6) as compared to presence of pro-inflammatory markers only. The odds for heart attack among those with diabetes, increased by 20 fold in presence of high levels of triglycerides, TNFα, and IL6 when coupled with low levels of high-density lipid cholesterol (HDL-C). Lastly, our analysis showed that poorly controlled diabetes, characterized by HbA1c values of > 6.5 increases the odds of stroke by more than three fold. The study quantifies the role of lipid profile and pro-inflammatory markers in combination with standard risk factors towards predicting the risk of CVD in those with type 2-diabetes. The findings from the study can be directly translated for use in early diagnosis of heart disease and guiding interventions leading to a reduction in CVD-associated mortality in those with type 2-diabetes.

Entities:  

Year:  2021        PMID: 33510184      PMCID: PMC7844256          DOI: 10.1038/s41598-021-81730-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  57 in total

1.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Authors:  Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

2.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 4.  Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.

Authors:  S M Grundy
Journal:  Am J Cardiol       Date:  1999-05-13       Impact factor: 2.778

Review 5.  Diabetes mellitus and inflammation.

Authors:  Eric Lontchi-Yimagou; Eugene Sobngwi; Tandi E Matsha; Andre Pascal Kengne
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

6.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

7.  Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.

Authors:  Andy Sun; Jean-San Chia; Yu-Fong Chang; Chun-Pin Chiang
Journal:  J Oral Pathol Med       Date:  2002-04       Impact factor: 4.253

Review 8.  Triglycerides as vascular risk factors: new epidemiologic insights.

Authors:  William B Kannel; Ramachandran S Vasan
Journal:  Curr Opin Cardiol       Date:  2009-07       Impact factor: 2.161

9.  Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies.

Authors:  Xiaofeng Ye; Wen Kong; Mohammad Ishraq Zafar; Lu-Lu Chen
Journal:  Cardiovasc Diabetol       Date:  2019-04-15       Impact factor: 9.951

10.  Normality tests for statistical analysis: a guide for non-statisticians.

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Int J Endocrinol Metab       Date:  2012-04-20
View more
  2 in total

1.  The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes.

Authors:  Fransina Ndevahoma; Bongani B Nkambule; Phiwayinkosi V Dludla; Munyaradzi Mukesi; Kandiwapa N Natanael; Tawanda M Nyambuya
Journal:  EJHaem       Date:  2021-07-06

2.  Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorate the Effect of Combined Oral Contraceptive- (COC-) Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats.

Authors:  Saheed Olanrewaju Afolabi; Joy Folahan; Olalekan Agede; Olufunke Olorundare
Journal:  Int J Reprod Med       Date:  2021-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.